What is the ticker symbol for Radiopharm Theranostics Limited?

Radiopharm Theranostics Limited trades under the ticker RADX on NASDAQ.

What sector does Radiopharm Theranostics Limited operate in?

Radiopharm Theranostics Limited is classified in the Healthcare sector (Biotechnology industry).

How can PortView help analyze RADX in a portfolio?

PortView shows RADX's weight in your portfolio, its contribution to return and risk, sector exposure, indirect exposure through ETFs you own, and correlation with your other holdings.

Radiopharm Theranostics Limited (RADX) Stock Analysis

NASDAQHealthcareBiotechnology

$2.30+1.32%

1-year price historyRange $2.26 – $10.63

52-week range$2.30

$2.04$16.25

What Radiopharm Theranostics Limited does

Radiopharm Theranostics Limited, an Australian company established in Carlton in 2021, specializes in the research and development of cutting-edge radiopharmaceutical treatments. Their mission is to address critical gaps in healthcare by creating products for both diagnostic imaging and therapeutic intervention across a spectrum of challenging medical conditions. The company's diverse pipeline features: RAD 204, designed to target PD-L1 for non-small cell lung cancer; RAD 202, aimed at HER2 for breast cancer and other solid tumor types; and two avß6 integrin-targeting agents, RAD 301 (a diagnostic tool for pancreatic ductal adenocarcinoma) and RAD 302 (a therapeutic agent for various cancers). Other significant developments include RAD 101 and RAD 102 for brain metastases, RAD 402 for advanced prostate cancer, and RV01 for multiple solid tumors. To accelerate the clinical progression of its radiopharmaceutical assets, Radiopharm Theranostics maintains a strategic partnership with Lantheus Holdings, Inc.

Key metrics

Market cap

$2.96M

P/E (TTM)

-0.39

EPS (TTM)

$-5.94

Beta

0.80

Dividend yield

0.00%

Revenue / share

$0.24

50-day avg

$3.43

200-day avg

$4.42

52-week high

$16.25

52-week low

$2.04

CEO

Riccardo Canevari

ETFs linked to RADX

Broad-market and Healthcare sector ETFs an investor holding Radiopharm Theranostics Limited is often also exposed to. Open an ETF page to see its actual top holdings.

SPY — SPDR S&P 500 ETF Trust VOO — Vanguard S&P 500 ETF QQQ — Invesco QQQ Trust VTI — Vanguard Total Stock Market ETF

PortView Portfolio Insights

PortView analyzes how RADX fits your actual portfolio — position weight, portfolio concentration, unrealized gain/loss, contribution to return, sector exposure, indirect exposure through the ETFs you hold, and correlation with your other holdings. Connect a portfolio to see your personalized figures; PortView never shows another user's private holdings.

Analyze RADX in PortView →

Similar companies

JNJ — Johnson &LLY — Eli Lilly A — Agilent Technologies ABBV — AbbVie Inc.ABT — Abbott Laboratories ALNY — Alnylam Pharmaceuticals

Frequently asked questions

What is the ticker symbol for Radiopharm Theranostics Limited?: Radiopharm Theranostics Limited trades under the ticker RADX on NASDAQ.
Which exchange is RADX listed on?: RADX is listed on NASDAQ.
What sector does Radiopharm Theranostics Limited operate in?: Radiopharm Theranostics Limited is classified in the Healthcare sector (Biotechnology industry).
How can PortView help analyze RADX in a portfolio?: PortView shows RADX's weight in your portfolio, its contribution to return and risk, sector exposure, indirect exposure through ETFs you own, and correlation with your other holdings.

The information provided by PortView is for informational and educational purposes only and does not constitute investment advice. Market data may be delayed. Past performance does not guarantee future results.